3 Worth Considering Stocks: Altria Group Inc(MO), Orbitz Worldwide, Inc.(OWW) and Arena Pharmaceuticals, Inc.(ARNA)

Posted by admin March 12, 2015 0 Comment 871 views

New York, NY – GDP INSIDER  –  03/12/2015.

This article discusses three companies: Altria Group Inc(NYSE:MO), Orbitz Worldwide, Inc.(NYSE:OWW) and Arena Pharmaceuticals, Inc.(NASDAQ:ARNA)

Altria Group Inc(NYSE:MO) declined 1.84% or $0.98 to close at $52.22 yesterday, on active trading volume of 9.01 million shares compared to its 30-day average trading volume of 6.63 million shares. However, the stock gained three cents to move to a value of $52.25 during afterhours trading. Over the past three months and over the past six months, the shares of Altria Group Inc have outperformed the S&P 500 index by 4.00% and 20.91%, respectively. The stock has an RSI value of 35.60, which indicates that the stock is not oversold at the current levels making it a worthwhile hold.

Should You Invest In Altria Group Inc Now? Learn More About Companies Trajectory In Our Free MO Analysis.

Orbitz Worldwide, Inc.(NYSE:OWW) saw its value increase by 0.17% as the stock gained two cents to move to a closing price of $11.71. More than 3.44 million shares exchanged hands during yesterday’s trading, a figure which is substantially lower than its 30-day average trading volume of 9.05 million. The global online travel company had a good year with the stock up 27.84% for the last 52 weeks, vastly outperforming the S&P500 which is also up 9.21% for the same period. The RSI of 72 indicates the stock is overbought at the current levels. The MFI reading of 72.44 indicates the money is flowing into the stock and it could be poised for another rally.

Is Growth What The Future Hold For Orbitz Worldwide, Inc? Find Out More In Our Free OWW Analysis.

Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) lost four cents to move to new closing price of $4.47, a 0.89% decrease in value from its previous closing price. The stock had a low trading volume of 4.00 million, a figure which is 1.28 million lower than its 30-day average trading volume of 5.28 million. Arena Pharmaceuticals, Inc has had a bad year with the stock down 37% for the last 52 weeks, substantially underperforming the S&P500 index which is up 9.21% for the same period. The RSI of 49.95 indicates the stock is not overvalued, the MFI of 43.39 show that money is flowing in the right direction and still has room to improve.

Why Arena Pharmaceuticals, Inc’s Risk/Reward Is Compelling For Investors? Click Here To Read Our Free ARNA Analysis.

About UltimateStockAlerts

UltimateStockAlerts.com provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word ULTIMATE to 555888 from your cell phone.

UltimateStockAlerts continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.

Disclosure:  UltimateStockAlerts is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit www.UltimateStockAlerts.com website, for complete risks and disclosures.

Write Your Comment